DrugPatentWatch Database Preview
Litigation Details for AbbVie Inc. v. Kennedy Inst. of Rheumatology (Fed. Cir. 2013)
» See Plans and Pricing
AbbVie Inc. v. Kennedy Inst. of Rheumatology (Fed. Cir. 2013)
| Docket | Start Trial | Date Filed | 2013-08-01 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | 2014-08-21 |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,015,557; 6,177,077 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in AbbVie Inc. v. Kennedy Inst. of Rheumatology
The biologic drugs covered by the patents cited in this case are Start Trial and Start Trial .
Details for AbbVie Inc. v. Kennedy Inst. of Rheumatology (Fed. Cir. 2013)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2013-12-01 | 21 | mediated diseases include rheumatoid 6,015,557 A 112000 Tobinick et al. …the challenged patent were not patentably distinct from those of the reference patent. Further, the…the challenged patent is patentably distinct from any claim of the reference patent. … ’442 patent. The relevant dates of Kennedy’s patents are depicted below: Patent No. … patent. Furthermore, the PTO’s finding that the claims of the ’442 patent are patent- | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
